15. Elki Sollenbring - Uppsala Monitoring Centre

•

5 recomendaciones•4,096 vistas

International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

Wednesday, 20 November, 2013 Latin America Biotherapeutic Conference Day 2

Salud y medicina

15. Elki Sollenbring - Uppsala Monitoring Centre

Más contenido relacionado

La actualidad más candente

The regulation of complementary medicinesTGA Australia

Establishing Pharmacovigilance Centres In Hospital.pptxRushikeshTidake

Drug utilisation evaluation Irene Vadakkan

Pharmacovigilance - a regulator's perspectiveTGA Australia

SAE Narrative WritingFernanda de Lima Ferreira

Adverse Drug ReactionPravin Prasad

Introduction to Pharmacovigilance| B- PHARM| PHARMACOVIGILANCEWorldofPharmacy

Causality assessment scaledrarunsingh4

Adverse drug reaction- Drug Interaction .pptxMangeshBansod2

PharmacovigilanceNaina Mohamed, PhD

Signal Detection in PharmacovigilanceClinosolIndia

FarmeLina R Fernandez

Algoritmo de naranjoVaLe Ramirez Elias

Causality Assessment in PharmacovigilanceClinosolIndia

PharmacoepidemiologyDrShrey Bhatia

PharmacoepidemiologyVibha Manu

Pharmaceutical care concepts - clinical pharmacy ShaistaSumayya

2 hospital pharmacy organisation and manage mentChanukya Vanam . Dr

Clinical literature evaluationSreenivasa Reddy Thalla

Drug-Induced Gastrointestinal Diseases (ADRs)Yvette Agatep

La actualidad más candente (20)

The regulation of complementary medicines

Establishing Pharmacovigilance Centres In Hospital.pptx

Drug utilisation evaluation

Pharmacovigilance - a regulator's perspective

SAE Narrative Writing

Adverse Drug Reaction

Introduction to Pharmacovigilance| B- PHARM| PHARMACOVIGILANCE

Causality assessment scale

Adverse drug reaction- Drug Interaction .pptx

Pharmacovigilance

Signal Detection in Pharmacovigilance

Farme

Algoritmo de naranjo

Causality Assessment in Pharmacovigilance

Pharmacoepidemiology

Pharmaceutical care concepts - clinical pharmacy

2 hospital pharmacy organisation and manage ment

Clinical literature evaluation

Drug-Induced Gastrointestinal Diseases (ADRs)

Más de International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

Peter Hotez, Baylor College of MedicineInternational Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

Session1: Patrick Deboyser, European UnionInternational Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

Session 4: Bejon Misra Partnership for Safe Medicines (PSM) INDIA / International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

Session 4 Sabine Walser Council of Europe / Legal framework necessary for eff...International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

Session 4: Domenico Di Giorgio AIFA Italy / SPOC model cooperation against co...International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

Session 3: Salmah Bahri - Ministry of Health, Malaysia / Monitoring of Counte...International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

Session 4: Sheuan Lee, International Council of Nurses (ICN) / Practices and ...International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

Session 3: Ivan Ho Pfizer / Counterfeit Medicines Threat to Patient Health an...International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

Session 3: Fu-Wen Chang, nternational Federation of Pharmaceutical Wholesaler...International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

Afternoon Session Opening: Jim Dahl, Partnership for Safe MedicinesInternational Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

Session 2: Mike Rose, Johnson & Johnson / Serialization and Traceability GS1 ...International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

Session 2: Scott Kammer, Rx360 International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

Opening Session - Cyntia Genole, IFPMAInternational Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

Session 1 - Mark Paxton, US FDA / APEC Roadmap to Promote Global Medical Prod...International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

Bringing Psoriasis into the Light, Kim kjoeller, Leo PharmaInternational Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

IFPA Psoriasis PresentationInternational Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

International Psoriasis Council, Steve O'DellInternational Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

Manaement of Psoriasis in Low Income CountriesInternational Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

IFPMA: From Manufacturing to the Vaccinee – the Complex Journey of a VaccineInternational Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

The Complex Journey of a VaccineInternational Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

Más de International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) (20)

Peter Hotez, Baylor College of Medicine

Session1: Patrick Deboyser, European Union

Session 4: Bejon Misra Partnership for Safe Medicines (PSM) INDIA /

Session 4 Sabine Walser Council of Europe / Legal framework necessary for eff...

Session 4: Domenico Di Giorgio AIFA Italy / SPOC model cooperation against co...

Session 3: Salmah Bahri - Ministry of Health, Malaysia / Monitoring of Counte...

Session 4: Sheuan Lee, International Council of Nurses (ICN) / Practices and ...

Session 3: Ivan Ho Pfizer / Counterfeit Medicines Threat to Patient Health an...

Session 3: Fu-Wen Chang, nternational Federation of Pharmaceutical Wholesaler...

Afternoon Session Opening: Jim Dahl, Partnership for Safe Medicines

Session 2: Mike Rose, Johnson & Johnson / Serialization and Traceability GS1 ...

Session 2: Scott Kammer, Rx360

Opening Session - Cyntia Genole, IFPMA

Session 1 - Mark Paxton, US FDA / APEC Roadmap to Promote Global Medical Prod...

Bringing Psoriasis into the Light, Kim kjoeller, Leo Pharma

IFPA Psoriasis Presentation

International Psoriasis Council, Steve O'Dell

Manaement of Psoriasis in Low Income Countries

IFPMA: From Manufacturing to the Vaccinee – the Complex Journey of a Vaccine

The Complex Journey of a Vaccine

Último

CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104

Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya

ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamAkebom Gebremichael

JANGAMA VISHA .pptx-Dr Anu Mariam Varghese

Musculoskeletal disorders: Osteoarthritis,.pptxraviapr7

SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1

Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners

Hypersensitivity and its classification .pptxAkshay Shetty

Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S

Primary headache and facial pain. (2024)Mohamed Rizk Khodair

Systemic Lupus Erythematosus -SLE PT2.pptraviapr7

HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...Divya Kanojiya

METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur

SGK HÓA SINH ENZYM 2006 CHỊ THU RẤT HAY.pdfHongBiThi1

Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar

PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi

Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0

Units of Radiation Measurements, Quality Specification, Half-Value Thickness,...Dr. Dheeraj Kumar

Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam

SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369